|
|
2025 Central region candidatesCandidates are listed alphabetically by surname. |
Tanja BangeHead of experimental medicine and group leader; PD PhD, Department of Medicine II, University Hospital, LMU Munich,Germany
In May 2025, I transitioned into a new position as Head of Experimental Medicine and Group Leader at the Department of Medicine II (Med2), University Hospital Großhadern, LMU Munich, which now allows me to actively engage with international communities such as HUPO. Previously, from 2018 to 2025, I was based at an institute with very limited travel and conference funding, which unfortunately restricted my ability to participate in HUPO activities, apart from attending the World Congress in Madrid in 2018. With this new chapter, I am excited to contribute to HUPO’s mission. I bring experience in interdisciplinary research, collaborative leadership, and mentoring across academic levels. I am particularly committed to supporting early-career scientists, promoting diversity, and advancing global exchange in proteomics. As a Council member, I would be honored to help shape the future of HUPO and its vibrant scientific community. Eva CsoszFull Professor, University of Debrecen, Hungary
As an elected Executive Committee member of the EuPA I am heavily involved in increasing the visibility of proteomics in Europe and fostering the interactions between the National Societies. In HUPO Council I had the chance to work in different working groups and if reelected I would like to continue applying my experience on a larger scale, to further increase the visibility of proteomics among life scientists, and foster communication among the research groups worldwide. As a mother of two daughters, I know how important is to maintain a healthy balance between the family and scientific life. If reelected, I will try to help mothers to achieve a scientific carrier, while taking care of the next generation. Peter HorvatovichProfessor in computational mass spextrometry, University of Groningen, Netherlands  I am honored to apply for a position on the HUPO Council, bringing over a decade of active leadership within the Human Proteome Project (HPP) and a research program dedicated to advancing proteomics through development of innovative bioinformatics approaches. As Secretary General of the Chromosome-Centric HPP (C-HPP) from 2012 to 2024, I have been deeply involved in shaping the global HPP agenda—co-organizing HPP and C-HPP workshops, initiating the C-HPP Wiki for transparent community data sharing, and contributing to HUPOST with C-HPP activities. I lead the Dutch Chromosome 5 C-HPP team and have contributed to multiple special issues of the Journal of Proteome Research, while actively engaging with the Mass Spectrometry Pillar of HUPO. My group develops novel approaches for proteogenomics data integration aimed at identifying protein variants with implications for personalized medicine. We are also exploring post-translational modifications (PTMs), particularly phosphorylation and glycation, to better understand disease mechanisms. Recently, we initiated new research directions in spatial proteomics and multi-omics integration to resolve biological complexity at tissue and cellular levels—key areas in line with HUPO’s One Health initiative. I am committed to HUPO’s mission of promoting proteomics through international cooperation, education, and translational science. With experience spanning collaborative leadership, technical innovation, and community engagement, I aim to further strengthen HUPO’s role as a unifying platform for proteomic discovery and application across health and disease. I bring an inclusive mindset and a strong drive to foster global connections between researchers, institutions, and scientific disciplines. As a HUPO Council member, I will advocate for open data initiatives, method standardization, and cross-pillar collaboration, ensuring that HUPO remains at the forefront of integrative, impactful science. Allan StensballeProfessor, Associate, Aalborg University, Denmark 
I am honoured to submit my candidacy for regional council membership of the Human Proteome Organization (HUPO) for the period of 2026-2028. For over two decades, I have been part of the Danish proteomics community and been dedicated to advancing the field of mass spectrometry and proteomics, both through innovative research and by actively supporting the collaborative community in Denmark as founding member of the Danish Proteomics Society and internationally through the EUPA and HUPO. My research focuses on applying cutting-edge mass spectrometry–based proteomics to address fundamental and translational biological questions focusing on autoimmune disorders. Since my early days in proteomics I have contributed to developing and refining analytical workflows and instrumentation for large-scale protein identification, quantification, and post-translational modification analysis of protein phosphorylation. Beyond the proteomics laboratory, I have consistently served the Danish proteomics community in leadership, organizational, and mentoring capacities. I have chaired and co-organized numerous national conferences and workshops, enabling knowledge exchange between early-career researchers and established leaders. I have also been an active contributor to HUPO’s initiatives including the hPOP and the C-HPP being responsible for CHR2, supporting its mission to promote proteomics worldwide and to drive the integration of proteomics into broader biomedical research. My vision for HUPO in the next years is to strengthen its role as a global hub for knowledge, standards, and policy in proteomics. As a council member, I will work to: Tim Van Den BosschePostdoctoral Researcher, Ghent University, Belgium
As one of the co-founders, I helped draft our mission and vision statement, as well as our proposals to become an official EuPA Initiative (since 2021), HUPO B/D-HPP Initiative (since 2023), and ELIXIR Microbiome collaborator (since 2024). As administrator, I coordinate internal meetings and agendas, steer the Executive Board, and help maintain the Initiative’s momentum. As a researcher, I took a leading role in the first CAMPI study (Nature Communications, 2021), its educational review (iMeta, 2025), and its standardization white paper (submitted, 2025). Beyond metaproteomics, I’ve always been actively involved in organizations, from contributing ideas and organizing events to shaping long-term strategies aligned with their mission and vision. Since my time as a Bachelor student, I’ve served on councils and commissions at Ghent University, up to and including the Board of Governors, where I was elected as the ECR representative and helped develop a framework to create a supportive academic culture (Nature Mental Health, 2025), among other initiatives. Having gained early-career policy experience and a strong commitment to community-building, I hope that, if re-elected, I can continue contributing as a HUPO Council Member and help shape the future of HUPO. Markku VarjosaloProgram Director, Professor, University of Helskinki, Finland 
I am Markku T. Varjosalo, a tenured Research Director and Professor at the Helsinki Institute of Life Science (HiLIFE), University of Helsinki. Over the past 20 years I have built and led a research programme that applies quantitative mass spectrometry and bioinformatics to decipher cell signalling and disease mechanisms. My training spans an M.Sc. in Biochemistry and Biotechnology from the University of Kuopio, a Ph.D. in Medical Systems Biology and a Docent degree in Molecular Systems Biology from the University of Helsinki. Since 2011 I have served as Scientific Director of the Helsinki Proteomics Center and, as Program Director for the Biomolecular Structure and Function Research Program at HiLIFE, I have secured substantial national and international funding and published more than 170 peer‑reviewed publications. My engagement with the proteomics community extends beyond my laboratory. As Scientific Director of the Helsinki Proteomics Center and a board member of the Finnish Proteomics Society, I have built core facilities and training programmes that serve researchers across the Nordic region. I am active in European infrastructures and societies, serving on the Executive Committee of Instruct‑ERIC and the Funding Committee of the European Proteomics Association. I have participated in HUPO congresses and related activities, including presenting my work, and I contribute to discussions that advance clinical proteomics and regional networking. Through these roles I have mentored numerous early‑career scientists and fostered collaborations spanning academia, industry and clinical medicine. If elected to the HUPO Council, I will ensure that voices from smaller nations are heard. I will advocate for equitable access to resources, strengthen links between HUPO and national societies, and promote interdisciplinary initiatives that integrate proteomics with genomics, metabolomics and clinical research. My experience in building research infrastructure, fostering collaboration and mentoring the next generation positions me to help HUPO remain at the forefront of scientific discovery. |
I am a molecular biologist and biochemist with long-standing expertise in proteomics, post-translational modifications, and protein degradation mechanisms. I was trained in the department of Prof. Matthias Mann (2007–2012), where I developed deep expertise in mass spectrometry (MS)-based proteomics. Since then, I have built a research profile at the interface of proteomics, cell signaling, and protein fate, with a focus on N-terminal modifications. I also established and led two MS facilities — at the Max Planck Institute of Molecular Physiology in Dortmund and at the LMU’s Institute of Medical Psychology in Munich. 
I am a full professor and deputy-head of department at the Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Hungary. I teach Proteomics and Biochemistry at the University of Debrecen in Hungary and Metabolomics at Babes-Bolyai University in Romania. As a leader of the Proteomics Core Facility and Biomarker research group I work together with students and researchers from different countries. I am the founder president of the Proteomics Division of the Hungarian Biochemical Society and the chair of the Conferences and Communication Committee of the European Proteomics Association (EuPA). In these various capacities, I’ve been able to experience the significance of the translation of proteomics results into biologically relevant information. Through my studies in Biochemistry and Molecular Biology and through the long years of communication with researchers from both academia and industry, I recognized the importance of proteomics for the broader life sciences, and conversely, the importance of the broader life sciences for the proteomics community. 
I am Tim Van Den Bossche, a postdoctoral researcher in metaproteomics bioinformatics. I am one of the co-founders and co-administrators of the Metaproteomics Initiative, a scientific community by and for metaproteomics researchers. In this community, we promote the dissemination of metaproteomics fundamentals, advancements, and applications through collaborative networking in microbiome research. 
.png)
INDUSTRIAL ADVISORY BOARD (IAB) MEMBERS
|
MENU | SUPPORT |